QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Galmed Pharmaceuticals (GLMD) Short Interest Ratio & Short Volume

$0.35
-0.02 (-5.80%)
(As of 04:32 PM ET)

Galmed Pharmaceuticals Short Interest Data

Current Short Volume
39,200 shares
Previous Short Volume
6,200 shares
Change Vs. Previous Month
+532.26%
Dollar Volume Sold Short
$13,574.96
Short Interest Ratio / Days to Cover
0.2
Last Record Date
March 31, 2024
Outstanding Shares
5,050,000 shares
Float Size
3,570,000 shares
Short Percent of Float
1.10%
Today's Trading Volume
96,270 shares
Average Trading Volume
194,585 shares
Today's Volume Vs. Average
49%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Galmed Pharmaceuticals ?

Sign up to receive the latest short interest report for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GLMD Short Interest Over Time

GLMD Days to Cover Over Time

GLMD Percentage of Float Shorted Over Time

Galmed Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202439,200 shares $13,574.96 +532.3%1.1%0.2 $0.35
3/15/20246,200 shares $1,891.62 -84.9%0.2%0 $0.31
2/29/202441,000 shares $16,322.10 -46.1%1.2%0.4 $0.40
2/15/202476,000 shares $28,887.60 +560.9%2.1%0.6 $0.38
1/31/202411,500 shares $4,311.35 -79.1%0.3%0.1 $0.37
1/15/202455,100 shares $25,015.40 -9.7%1.5%0.3 $0.45
12/31/202361,000 shares $27,755.00 +65.3%1.7%0.4 $0.46
12/15/202336,900 shares $13,165.92 -56.9%1.0%0.2 $0.36
11/30/202385,700 shares $30,423.50 +564.3%2.4%0.4 $0.36
11/15/202312,900 shares $5,160.00 +17.3%0.4%0.1 $0.40
10/31/202311,000 shares $4,180.00 -1.8%0.3%0.2 $0.38
10/15/202311,200 shares $4,592.00 +75.0%0.3%0.1 $0.41
9/30/20236,400 shares $3,968.00 +88.2%0.2%0 $0.62
9/15/20233,400 shares $2,515.66 -52.8%0.1%0 $0.74
8/31/20237,200 shares $5,824.80 -32.7%0.2%0 $0.81
8/15/202310,700 shares $8,669.14 -61.1%0.3%0 $0.81
7/31/202327,500 shares $31,625.00 -92.3%1.5%0.1 $1.15
7/15/2023357,100 shares $517,795.00 +2,668.2%20.1%1.3 $1.45
6/30/202312,900 shares $37,539.00 -6.5%0.9%0.1 $2.91
6/15/202313,800 shares $51,474.00 -14.3%1.0%0.5 $3.73
5/31/202316,100 shares $74,221.00 -18.7%1.1%0.7 $4.61
5/15/202319,800 shares $0.00 +1,700.0%1.4%0.9 $0.00
4/30/202317,200 shares $5,332.00 -6.5%0.1%0.1 $0.31
4/15/202318,400 shares $5,704.00 -30.3%0.1%0.3 $0.31
3/31/202326,400 shares $11,259.60 -28.5%0.1%0.3 $0.43
3/15/202336,900 shares $17,239.68 +58.4%0.2%0.3 $0.47
2/28/202323,300 shares $11,184.00 -32.1%0.1%0.2 $0.48
2/15/202334,300 shares $20,923.00 +106.6%0.2%0.2 $0.61
1/31/202316,600 shares $10,974.26 -88.4%0.1%0.1 $0.66
1/15/2023143,500 shares $115,058.30 -2.3%0.7%1.1 $0.80
12/30/2022146,900 shares $73,450.00 +57.3%0.7%1.3 $0.50
12/15/202293,400 shares $27,086.00 +233.6%0.4%1.1 $0.29
11/30/202228,000 shares $8,173.20 +53.0%0.1%0.8 $0.29
11/15/202218,300 shares $6,101.22 -45.9%0.1%0.4 $0.33
10/31/202233,800 shares $12,847.38 +80.8%0.2%0.6 $0.38
10/15/202218,700 shares $7,264.95 +22.2%0.1%0.3 $0.39
9/30/202215,300 shares $4,759.59 -57.5%0.1%0.2 $0.31
9/15/202236,000 shares $16,563.60 -35.5%0.2%0.4 $0.46
8/31/202255,800 shares $25,896.78 +234.1%0.3%0.5 $0.46
8/15/202216,700 shares $7,424.82 -34.0%0.1%0.2 $0.44
Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

GLMD Short Interest - Frequently Asked Questions

What is Galmed Pharmaceuticals' current short interest?

Short interest is the volume of Galmed Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 39,200 shares of GLMD short. 1.10% of Galmed Pharmaceuticals' shares are currently sold short. Learn More on Galmed Pharmaceuticals' current short interest.

Which institutional investors are shorting Galmed Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Galmed Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Galmed Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.10% of Galmed Pharmaceuticals' floating shares are currently sold short.

Is Galmed Pharmaceuticals' short interest increasing or decreasing?

Galmed Pharmaceuticals saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 39,200 shares, an increase of 532.3% from the previous total of 6,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Galmed Pharmaceuticals' float size?

Galmed Pharmaceuticals currently has issued a total of 5,050,000 shares. Some of Galmed Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galmed Pharmaceuticals currently has a public float of 3,570,000 shares.

How does Galmed Pharmaceuticals' short interest compare to its competitors?

1.10% of Galmed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Galmed Pharmaceuticals: Bellerophon Therapeutics, Inc. (0.55%), Aditxt, Inc. (0.99%), Evelo Biosciences, Inc. (2.11%), China SXT Pharmaceuticals, Inc. (4.78%), Neptune Wellness Solutions Inc (0.54%), TransCode Therapeutics, Inc. (0.61%), Athersys, Inc. (12.51%), Comera Life Sciences Holdings, Inc. (2.38%), Baudax Bio, Inc. (1.11%), SciSparc Ltd. (24.15%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Galmed Pharmaceuticals stock?

Short selling GLMD is an investing strategy that aims to generate trading profit from Galmed Pharmaceuticals as its price is falling. GLMD shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Galmed Pharmaceuticals?

A short squeeze for Galmed Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLMD, which in turn drives the price of the stock up even further.

How often is Galmed Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLMD, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:GLMD) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners